Sub-chronic dietary tryptophan depletion--an animal model of depression with improved face and good construct validity

J Psychiatr Res. 2012 Feb;46(2):239-47. doi: 10.1016/j.jpsychires.2011.10.003. Epub 2011 Nov 8.

Abstract

Sub-chronic tryptophan depletion (SCTD) is proposed as an animal model for depression. Aims were to test the hypothesis and optimise the time of SCTD-induced depression-related behaviour and associated biochemical changes. Sprague Dawley rats were treated with a low tryptophan (TRP) containing diet for 0, 7 or 14 days. Peripheral and central neurochemical markers were measured. SCTD-induced depression-related behaviour was assessed by the forced swim test (FST). Model sensitivity to antidepressants was tested by concomitant treatment with paroxetine. SCTD-induced significant reductions in weight gain and measures of peripheral and central TRP. Corticosterone, aldosterone and kynurenine (K), increased whilst kynurenic acid (KA), an NMDA antagonist decreased. 5-HT(2) receptor binding Bmax was enhanced but was reversed by paroxetine. Corticosterone and aldosterone were significantly negatively-correlated to weight gain. SCTD increased floating time and reduced swimming time in the FST but were reversed by paroxetine. Aldosterone was increased at 7 and 14 days, whereas other changes maximised at 14 days. Aldosterone may be an early marker or causal link for depression development. Increased corticosterone and brain tissue 5-HT-receptor density may be correlates of depressive behaviour. Consequential increases in NMDA signalling through increased K/KA ratios suggest the model may be useful for testing novel antidepressants.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aldosterone / blood
  • Analysis of Variance
  • Animals
  • Body Weight / physiology
  • Brain / metabolism
  • Calcium-Binding Proteins / blood
  • Catecholamines / metabolism
  • Chromatography, High Pressure Liquid / methods
  • Corticosterone / blood
  • DNA-Binding Proteins / blood
  • Depression / etiology*
  • Depression / pathology
  • Diet / adverse effects
  • Disease Models, Animal
  • Kynurenic Acid / metabolism
  • Kynurenine / metabolism
  • Kynurenine / pharmacokinetics
  • Male
  • Nerve Tissue Proteins / blood
  • Nucleobindins
  • Paroxetine / therapeutic use
  • Protein Binding / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Reproducibility of Results
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Swimming / psychology
  • Time Factors
  • Tritium / pharmacokinetics
  • Tryptophan / deficiency*

Substances

  • Calcium-Binding Proteins
  • Catecholamines
  • DNA-Binding Proteins
  • Nerve Tissue Proteins
  • Nucleobindins
  • Serotonin Uptake Inhibitors
  • Tritium
  • Kynurenine
  • Paroxetine
  • Aldosterone
  • Tryptophan
  • Kynurenic Acid
  • Corticosterone